|
|
|
|
MUTATION | |
AATAAA->AATAAG of the alpha2 gene (poly A signal) | |
|
AMINO ACID REPLACEMENT | |
None | |
TYPE OF ALPHA-THAL | |
alpha-Thal-2 [alpha(T)alpha/alphaalpha] | |
MECHANISM | |
This mutation in the poly A signal results in an extended transcript with a new signal 1048 bp 3' to the terminating codon; nonfunctional mRNA | |
IDENTIFICATION | |
Cloning or amplification of the alpha2-globin gene; DNA se-quencing; dot-blot analysis with allele specific probes; ASO | |
HEMATOLOGY IN HETEROZYGOTE(S) | |
For hematological and Hb composition data see table from Ref. 4 (below) | |
| |
Sex-Age | Hb g/dl | PCV l/l | RBC 1012/l | MCV fl | MCH pg | MCHC g/dl | A2 % | % H + Bart's |
| Homozygotes (n = 7) | F-10 M-14 F-42 F-21 M-16 Adult M-13 | 7.0 7.0 9.7 9.0 9.9 7.7 8.6 | 0.289 0.295 0.424 0.393 0.421 0.290 0.306 | 3.94 3.90 5.25 4.72 5.14 4.05 4.37 | 73.4 75.6 80.5 83.5 82.0 71.6 70.0 | 17.8 17.9 18.4 19.1 19.3 19.0 19.5 | 24.2 23.7 22.9 23.5 26.6 28.0 28.1 | 0.7 1.4 0.6 0.7 0.7 0.8 1.4 | 14.0 6.5 7.0 20.0 25.0 n.d. 17.0 | Average | 8.4 | 0.345 | 4.48 | 77.0 | 18.8 | 24.3 | 0.9 | 15.0 |
| Heterozygotes (n = 10) | F-adult M-adult F-adult M-adult M-adult M-adult M-adult M-adult F-adult F-adult | 12.6 12.6 10.9 13.3 10.8 16.4 15.2 13.5 14.6 11.9 | 0.459 0.460 0.377 0.465 0.381 0.560 0.476 0.418 0.451 0.352 | 5.12 5.15 4.37 5.22 4.64 6.60 5.80 5.10 5.50 4.60 | 89.6 89.3 86.3 89.1 82.1 84.3 82.1 82.0 82.0 77.0 | 24.6 24.5 24.9 25.5 23.3 24.7 26.2 26.5 26.5 25.8 | 27.5 27.4 28.9 28.6 28.3 29.3 31.9 32.3 32.1 33.8 | 2.2 2.5 2.4 2.5 2.4 2.2 2.1 2.4 2.7 2.8 | 0 0 0 0 0 0 0 0 0 0 | Average | 13.2 | 0.440 | 5.21 | 84.5 | 25.3 | 30.0 | 2.4 | 0 |
| | |
HEMATOLOGY IN HOMOZYGOTE(S) | |
Homozygosity expresses as Hb H disease probably because the presence of an extended transcript reduces the expression of the 3' alpha1-globin gene | |
OCCURRENCE | |
In Arabian populations | |
HAPLOTYPE | |
Not determined | |
FOUND IN COMBINATION WITH ABNORMAL HB(S) | |
Not reported | |
FOUND IN COMBINATION | |
With different alpha-thal alleles (deletional and nondeletional mutations) | |
OTHER INFORMATION | |
None | |
|
|
|
|
REFERENCES |
1. | |
Higgs, D.R., Goodbourn, S.E.Y., Lamb, J., Clegg, J.B., Weatherall, D.J., and Proudfoot, N.J.: Nature, 306:398, 1983. | |
2. | |
Thein, S.L., Wallace, R.B., Pressley, L., Clegg, J.B., Weatherall, D.J., and Higgs, D.R.: Blood, 71:313, 1988. | |
3. | |
Whitelaw, E. and Proudfoot, N.: EMBO J., 5:2915, 1986. | |
4. | |
Fei, Y-J., Oner, R., Bozkurt, G., Gu, L-H., Altay, Ç., Gurgey, A., Fattoum, S., Baysal, E., and Huisman, T.H.J.: Acta Haematol., 88:82, 1992. | |
5. | |
Adekile, A.D., Gu, L-H., Baysal, E., Haider, M.Z., Al-Fuzae, L., Aboobacker, K.C., Al-Rashied, A., and Huisman, T.H.J.: Acta Haematol., 92:176, 1994. | |